Publication date: 2018-09-20 05:38
Research in 7567 looked at the role that SSRIs play in weight gain and found that specific risk factors increased the likelihood of a person gaining weight when taking these antidepressants. These factors included:
Angle Closure Glaucoma : The pupillary dilation that occurs following use of many antidepressant drugs including Lexapro may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction , including: rash , itching /swelling (especially of the face/ tongue /throat), severe dizziness, trouble breathing.
Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.
The absolute bioavailability of citalopram is about 85% relative to an intravenous dose, and the volume of distribution of citalopram is about 67 L/kg. Data specific on escitalopram are unavailable.
Depression in teenagers may be caused by many factors. Symptoms of teen depression include apathy, irresponsible behavior,.
This medication may increase serotonin and rarely cause a very serious condition called serotonin syndrome /toxicity. The risk increases if you are also taking other drugs that increase serotonin, so tell your doctor or pharmacist of all the drugs you take (see Drug Interactions section). Get medical help right away if you develop some of the following symptoms: fast heartbeat, hallucinations , loss of coordination, severe dizziness, severe nausea / vomiting / diarrhea , twitching muscles, unexplained fever , unusual agitation/restlessness.
Skin and Subcutaneous Tissue Disorders : alopecia , angioedema , dermatitis , ecchymosis , erythema multiforme , photosensitivity reaction, Stevens Johnson Syndrome, toxic epidermal necrolysis, urticaria.
Initial dose: 65 mg orally once a day increase if necessary after at least 6 week of treatment to 75 mg once a day
Maintenance dose: 65 to 75 mg orally once a day
Maximum dose: 75 mg orally once a day
Comment: Treatment should be periodically reassessed to determine the need for ongoing treatment efficacy beyond 8 weeks has not been systematically studied.
Use: Acute treatment of generalized anxiety disorder
Learn about phobias such as agoraphobia, claustrophobia, arachnophobia, and more. Discover some of the symptoms and.